Supply of CAR-T preparations (axicabtagene ciloleucel, lisocabtagene maraleucel)
Titre original de l'avis
Poland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – DZP.242.281.2026 -Dostawa produktów leczniczych – preparaty CAR-T [Axicabtagene ciloleucel, Lisocabtagene maraleucel]
Score d'opportunité
Pourquoi ce score ?
Opportunité
50 / 100
Complexité
25 / 100
Facteurs de risque
No estimated value disclosed; may indicate low budget or hidden constraints.
Structured data indicates EU funding, XML indicates no EU funds. Could affect contract terms or audit requirements.
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Informations clés
- Pouvoir adjudicateur
- UNIWERSYTECKI SZPITAL KLINICZNY IM. JANA MIKULICZA-RADECKIEGO WE WROCŁAWIU
- Pays
- Pologne
- CPV
- 33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
- Date limite
- Jul 27, 2026
Aperçu
Moderate opportunityFaits clés
- Supplies contract
- 2 lots
- Duration 12 MONTH
- Supply of CAR-T medicinal products: Axicabtagene ciloleucel (Lot 1) and Lisocabtagene maraleucel (Lot 2).
- Delivery to Wrocław, Poland.
Afficher le résumé complet
Open tender by Uniwersytecki Szpital Kliniczny we Wrocławiu for supply of CAR-T medicinal products: Axicabtagene ciloleucel (Lot 1) and Lisocabtagene maraleucel (Lot 2). Two lots, each for one task. Award based solely on lowest price. Duration 12 months. No financial or technical eligibility conditions required beyond standard business registration and, for pharmaceutical wholesalers, a permit from the Chief Pharmaceutical Inspector. Estimated value not disclosed. EU funding flag inconsistent between structured data (true) and XML (no EU funds). Language of procedure: Polish. Deadline for submission: 2026-07-27 10:00 Warsaw time.
Risques
No estimated value disclosed; may indicate low budget or hidden constraints.
Structured data indicates EU funding, XML indicates no EU funds. Could affect contract terms or audit requirements.
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- Tenderers must be registered in KRS (Poland) or equivalent business register.
- Pharmaceutical wholesalers must hold a permit from the Chief Pharmaceutical Inspector under the Pharmaceutical Law.
Administrative
- Electronic submission via the procurement platform (platformazakupowa.pl).
Critères d'attribution
Lot 1
Lot 2
Acheteur
Localisation
WROCŁAW, POL
Site web
Profil acheteur
Identifiant
8981816856
Activité
Health
Lots (2)
LOT-0001
Position 1 - Axicabtagene ciloleucel
Supply of Axicabtagene ciloleucel (CAR-T therapy). One task. Duration 12 months. Place of performance: Wrocław, Poland.
PLN 0
Valeur estimée
Localisation
Durée
Catégorie
Critères d'attribution
Date limite
Détails des critères
Za ofertę najkorzystniejszą zostanie uznana oferta zawierająca najniższą cenę: „Cena” – C
Note sur la valeur
Afficher les données TED originales
Titre original du lot
POZYCJA NR 1
Description TED originale
POZYCJA NR 1 - Axicabtagene ciloleucel - 1 ZADANIE
LOT-0002
Position 2 - Lisocabtagene maraleucel
Supply of Lisocabtagene maraleucel (CAR-T therapy). One task. Duration 12 months. Place of performance: Wrocław, Poland.
PLN 0
Valeur estimée
Localisation
Durée
Catégorie
Critères d'attribution
Date limite
Détails des critères
Za ofertę najkorzystniejszą zostanie uznana oferta zawierająca najniższą cenę: „Cena” – C
Note sur la valeur
Afficher les données TED originales
Titre original du lot
POZYCJA NR 2
Description TED originale
POZYCJA NR 2 - Lisocabtagene maraleucel - 1 ZADANIE
Détails de la procédure
- Date de publication
- 24 Jun 2026
- Langues
- Polish
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 435226-2026
Documents (1)
Appels d'offres similaires
Czechia – Specialised chemical products – DNS - chemikálie pro molekulární a buněčnou biologii
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Lithuania – Pharmaceutical products – Vaistų ir kitų farmacijos produktų pirkimas
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на ВМА и подчинените й структури
Lithuania-Kaunas: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Score d'opportunité
Pourquoi ce score ?
Opportunité
50 / 100
Complexité
25 / 100
Facteurs de risque
No estimated value disclosed; may indicate low budget or hidden constraints.
Structured data indicates EU funding, XML indicates no EU funds. Could affect contract terms or audit requirements.
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications